Difelikefalin suppresses itch and reduces scratching independent of inflammation in a murine model of atopic dermatitis

Therapies specifically targeting nonhistaminergic pruritus are largely lacking. Difelikefalin (DFK) has been found to reduce itch in various chronic pruritic conditions, including atopic dermatitis (AD).